{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:41:50Z","timestamp":1792590110772,"version":"4.5.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023334","name":"Fondation Des \u00c9toiles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cjca.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T01:22:39Z","timestamp":1726363359000},"page":"2496-2511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Meta-Analysis of Risk Factors for Congenital Heart Disease: Part 2, Maternal Medication, Reproductive Technologies, and Familial and Fetal Factors"],"prefix":"10.1016","volume":"40","author":[{"given":"Alyssia","family":"Lemieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Khalilipalandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lauzon-Schnittka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Taillefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Tousignant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lodie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Watelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Olivier","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-2523","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Dallaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2024.09.011_bib1","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/01.CIR.103.19.2376","article-title":"Mortality associated with congenital heart defects in the United States","volume":"103","author":"Boneva","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.09.011_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.013796","article-title":"Incremental detection of severe congenital heart disease by fetal echocardiography following a normal second trimester ultrasound scan in Qu\u00e9bec, Canada","volume":"15","author":"Cardinal","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1161\/CIRCULATIONAHA.106.183216","article-title":"Noninherited risk factors and congenital cardiovascular defects: current knowledge","volume":"115","author":"Jenkins","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.09.011_bib4","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","article-title":"Diagnosis and treatment of fetal cardiac disease","volume":"129","author":"Donofrio","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.cjca.2024.07.004","article-title":"Systematic review and meta-analysis of prenatal risk factors for congenital heart disease: part 1, maternal chronic diseases and parental exposures","volume":"40","author":"Khalilipalandi","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib6","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2024.09.011_bib7","author":"Wells"},{"key":"10.1016\/j.cjca.2024.09.011_bib8","author":"Deeks"},{"key":"10.1016\/j.cjca.2024.09.011_bib9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1080\/14767058.2017.1408067","article-title":"Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland","volume":"32","author":"Alanen","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/uog.1936","article-title":"Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype","volume":"26","author":"Atzei","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1067\/mob.2002.128025","article-title":"Midtrimester nuchal thickness and the prediction of postnatal congenital heart defect","volume":"187","author":"Bahado-Singh","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ajog.2004.12.086","article-title":"Elevated first-trimester nuchal translucency increases the risk of congenital heart defects","volume":"192","author":"Bahado-Singh","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajmg.a.38013","article-title":"Critical congenital heart defects and abnormal levels of routinely collected first- and second-trimester biomarkers","volume":"173","author":"Borelli","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cjca.2024.09.011_bib14","first-page":"307","article-title":"The role of nuchal translucency in the screening for congenital heart defects","volume":"87","author":"Bruns","year":"2006","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.0960-7692.2001.00584.x","article-title":"Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype","volume":"18","author":"Ghi","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/pd.721","article-title":"Increased nuchal translucency and congenital heart defects in a low-risk population","volume":"23","author":"Hafner","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cjca.2024.09.011_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.318.7176.81","article-title":"Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study","volume":"318","author":"Hyett","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"518.e1","DOI":"10.1016\/j.ajog.2014.10.1102","article-title":"Risk of critical congenital heart defects by nuchal translucency norms","volume":"212","author":"Jelliffe-Pawlowski","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1469-0705.2001.00342.x","article-title":"Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects","volume":"17","author":"Mavrides","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1469-0705.2001.00341.x","article-title":"Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses","volume":"17","author":"Michailidis","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/uog.21956","article-title":"Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus","volume":"55","author":"Minnella","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.cjca.2024.09.011_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.AOG.0000250473.99575.72","article-title":"Nuchal translucency and the risk of congenital heart disease","volume":"109","author":"Simpson","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/pd.1643","article-title":"Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies","volume":"27","author":"M\u00fcller","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cjca.2024.09.011_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/pd.4282","article-title":"Prenatal diagnosis of nonsyndromic congenital heart defects","volume":"34","author":"Ailes","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cjca.2024.09.011_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/tera.1420500208","article-title":"Ebstein\u2019s malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group","volume":"50","author":"Correa-Villase\u00f1or","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.cjca.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00246-014-0922-6","article-title":"Prevalence of associated extracardiac malformations in the congenital heart disease population","volume":"35","author":"Egbe","year":"2014","journal-title":"Pediatric Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/tera.1420410309","article-title":"Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus","volume":"41","author":"Ferencz","year":"1990","journal-title":"Teratology"},{"key":"10.1016\/j.cjca.2024.09.011_bib28","article-title":"Impact of prenatal risk factors on congenital heart disease in the current era","volume":"2","author":"Fung","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2024.09.011_bib29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1177\/000992280204100903","article-title":"Risk factors in congenital heart disease","volume":"41","author":"Roodpeyma","year":"2002","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.cjca.2024.09.011_bib30","first-page":"1524","article-title":"Consanguineous marriage and congenital heart defects: a case-control study in the neonatal period","volume":"140","author":"Yunis","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cjca.2024.09.011_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF00146368","article-title":"Risk factors for atrial septal defect","volume":"8","author":"Tikkanen","year":"1992","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0735-1097(89)90199-X","article-title":"Risk factors for conotruncal cardiac defects in Atlanta","volume":"14","author":"Adams","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib33","first-page":"1","article-title":"Risk factors of congenital heart diseases: a hospital-based case-control study in Isfahan, Iran","volume":"16","author":"Ahmadi","year":"2020","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.cjca.2024.09.011_bib34","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.15537\/smj.2020.10.25418","article-title":"Risk factors for transposition of the great arteries in Saudi population","volume":"41","author":"Alfarhan","year":"2020","journal-title":"Saudi Med J"},{"key":"10.1016\/j.cjca.2024.09.011_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.arcmed.2018.06.001","article-title":"Maternal obesity as a risk factor for the development of total anomalous pulmonary venous connection in their offspring","volume":"49","author":"Alvarado-Terrones","year":"2018","journal-title":"Arch Med Res"},{"key":"10.1016\/j.cjca.2024.09.011_bib36","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1542\/peds.2010-1399","article-title":"Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study","volume":"127","author":"Alverson","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.cjca.2024.09.011_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/A:1007601919164","article-title":"Risk factors for congenital heart diseases in Alexandria, Egypt","volume":"16","author":"Bassili","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpeds.2021.09.005","article-title":"National Birth Defects Prevention Study. Maternal smoking and congenital heart defects:, 1997-2011","volume":"240","author":"Bolin","year":"2022","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cjca.2024.09.011_bib39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1023\/A:1025312603880","article-title":"Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy)","volume":"18","author":"Calzolari","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/bdra.23128","article-title":"Periconceptional paternal smoking and the risk of congenital heart defects: a case-control study","volume":"97","author":"Deng","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cjca.2024.09.011_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18909-y","article-title":"Association between maternal smoke exposure and congenital heart defects from a case\u2013control study in China","volume":"12","author":"Deng","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjca.2024.09.011_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026268","article-title":"Associations and interaction effects of maternal smoking and genetic polymorphisms of cytochrome P450 genes with risk of congenital heart disease in offspring: a case-control study","volume":"100","author":"Diao","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cjca.2024.09.011_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1017\/S1047951119000970","article-title":"Potential risk factors for Ebstein anomaly: National Birth Defects Prevention Study, 1997-2011","volume":"29","author":"Downing","year":"2019","journal-title":"Cardiol Young"},{"key":"10.1016\/j.cjca.2024.09.011_bib44","doi-asserted-by":"crossref","first-page":"51.e1","DOI":"10.1016\/j.ajog.2009.08.005","article-title":"Association between prepregnancy body mass index and congenital heart defects","volume":"202","author":"Gilboa","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib45","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1186\/s12889-021-11034-x","article-title":"Incidence and risk factors of congenital heart disease in Qingdao: a prospective cohort study","volume":"21","author":"Jin","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cjca.2024.09.011_bib46","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.7150\/ijms.48046","article-title":"A\u00a0predictive model of offspring congenital heart disease based on maternal risk factors during pregnancy: a hospital based case-control study in Nanchong City","volume":"17","author":"Liang","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.cjca.2024.09.011_bib47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.112.001054","article-title":"Association between maternal chronic conditions and congenital heart defects: a population-based cohort study","volume":"128","author":"Liu","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.09.011_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/1096-9926(200102)63:2<87::AID-TERA1014>3.0.CO;2-5","article-title":"Atrioventricular septal defects: possible etiologic differences between complete and partial defects","volume":"63","author":"Loffredo","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.cjca.2024.09.011_bib49","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1542\/peds.2007-1519","article-title":"Maternal smoking and congenital heart defects","volume":"121","author":"Malik","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.cjca.2024.09.011_bib50","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jpeds.2010.11.058","article-title":"Associations between maternal fever and influenza and congenital heart defects","volume":"158","author":"Oster","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cjca.2024.09.011_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCULATIONAHA.109.857987","article-title":"Recurrence of congenital heart defects in families","volume":"120","author":"\u00d8yen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.09.011_bib52","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/bdr2.1501","article-title":"Collins RT 2nd; National Birth Defects Prevention Study. Risk factors associated with the development of double-inlet ventricle congenital heart disease","volume":"111","author":"Paige","year":"2019","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.cjca.2024.09.011_bib53","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/ajmg.a.35555","article-title":"Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005","volume":"158A","author":"Patel","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cjca.2024.09.011_bib54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1034\/j.1399-0004.2001.590505.x","article-title":"The risk for congenital heart defects in offspring of individuals with congenital heart defects","volume":"59","author":"Romano-Zelekha","year":"2001","journal-title":"Clin Genet"},{"key":"10.1016\/j.cjca.2024.09.011_bib55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.32604\/CHD.2021.015862","article-title":"Noninherited factors in fetal congenital heart diseases based on bayesian network: a large multicenter study","volume":"16","author":"Ruan","year":"2021","journal-title":"Congen Heart Dis"},{"key":"10.1016\/j.cjca.2024.09.011_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1017\/S1047951116000202","article-title":"Elevated birth prevalence of conotruncal heart defects in a population with high consanguinity rate","volume":"27","author":"Stavsky","year":"2017","journal-title":"Cardiol Young"},{"key":"10.1016\/j.cjca.2024.09.011_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2478\/abm-2021-0033","article-title":"Parental risk factors associated with congenital heart disease in a Thai population: multivariable analysis","volume":"15","author":"Suwansumrit","year":"2021","journal-title":"Asian Biomed"},{"key":"10.1016\/j.cjca.2024.09.011_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3126\/jnps.v33i2.8254","article-title":"Study of risk factor for congenital heart diseases in children at rural hospital of central India","volume":"33","author":"Taksande","year":"2013","journal-title":"J\u00a0Nepal Paediatr Soc"},{"key":"10.1016\/j.cjca.2024.09.011_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0033-3506(05)80283-5","article-title":"Risk factors for ventricular septal defect in Finland","volume":"105","author":"Tikkanen","year":"1991","journal-title":"Public Health"},{"key":"10.1016\/j.cjca.2024.09.011_bib60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0974-2069.84641","article-title":"Risk factors predisposing to congenital heart defects","volume":"4","author":"Ul Haq","year":"2011","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib61","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/bdra.23265","article-title":"Periconceptional parental conditions and perimembranous ventricular septal defects in the offspring","volume":"100","author":"Wijnands","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cjca.2024.09.011_bib62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12872-019-1206-0","article-title":"Associations of maternal upper respiratory tract infection\/influenza during early pregnancy with congenital heart disease in offspring: evidence from a case-control study and meta-analysis","volume":"19","author":"Xia","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2024.09.011_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/bdra.23352","article-title":"Maternal periconceptional alcohol consumption and congenital heart defects","volume":"103","author":"Zhu","year":"2015","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cjca.2024.09.011_bib64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<42::AID-AJMG8>3.0.CO;2-S","article-title":"Paternal risk factors for isolated membranous ventricular septal defects","volume":"71","author":"Ewing","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cjca.2024.09.011_bib65","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/aogs.14225","article-title":"High maternal blood lipid levels during early pregnancy are associated with increased risk of congenital heart disease in offspring","volume":"100","author":"Cao","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.cjca.2024.09.011_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10995-015-1804-0","article-title":"Maternal chlamydia infection during pregnancy and risk of cyanotic congenital heart defects in the offspring","volume":"20","author":"Dong","year":"2016","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.cjca.2024.09.011_bib67","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s42399-021-01055-3","article-title":"Association between maternal race and the occurrence of cyanotic congenital heart disease in the USA","volume":"3","author":"Ebeh","year":"2021","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/uog.20149","article-title":"Impaired placental perfusion and major fetal cardiac defects","volume":"53","author":"Fantasia","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib69","first-page":"217","article-title":"Comparison of congenital abnormalities of infants conceived by assisted reproductive techniques versus infants with natural conception in Tehran","volume":"7","author":"Farhangniya","year":"2013","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.cjca.2024.09.011_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227908","article-title":"Risk factors for congenital heart disease: the Baby Hearts Study, a population-based case-control study","volume":"15","author":"Dolk","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2024.09.011_bib71","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010035","article-title":"The risk of major birth defects after intracytoplasmic sperm injection and in\u00a0vitro fertilization","volume":"346","author":"Hansen","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib72","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/AOG.0b013e318269c282","article-title":"Assisted reproductive technology and major birth defects in Western Australia","volume":"120","author":"Hansen","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/bdra.23355","article-title":"Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments","volume":"103","author":"Heisey","year":"2015","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cjca.2024.09.011_bib74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/14647273.2016.1254352","article-title":"Reproductive technologies and the risk of congenital heart defects","volume":"20","author":"Iwashima","year":"2017","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.cjca.2024.09.011_bib75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","article-title":"Maternal drug use in early pregnancy and infant cardiovascular defect","volume":"17","author":"K\u00e4ll\u00e9n","year":"2003","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.cjca.2024.09.011_bib76","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.fertnstert.2003.10.053","article-title":"Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study","volume":"81","author":"Katalinic","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjca.2024.09.011_bib77","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.fertnstert.2005.03.085","article-title":"Children born after assisted fertilization have an increased rate of major congenital anomalies","volume":"84","author":"Klemetti","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjca.2024.09.011_bib78","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/humrep\/17.5.1391","article-title":"Neonatal outcome and congenital malformations in children born after in-vitro fertilization","volume":"17","author":"Koivurova","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cjca.2024.09.011_bib79","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/bmj.315.7118.1260","article-title":"Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation","volume":"315","author":"Kurinczuk","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2024.09.011_bib80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41390-020-01274-9","article-title":"Maternal alcohol consumption and risk of offspring with congenital malformation: the Japan Environment and Children\u2019s Study","volume":"90","author":"Kurita","year":"2021","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cjca.2024.09.011_bib81","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.fertnstert.2005.03.086","article-title":"In\u00a0vitro fertilization is associated with an increase in major birth defects","volume":"84","author":"Olson","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjca.2024.09.011_bib82","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2016.05.029","article-title":"Congenital heart disease in twins: the contribution of type of conception and chorionicity","volume":"218","author":"Panagiotopoulou","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib83","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/humrep\/der443","article-title":"Similarly increased congenital anomaly rates after intrauterine insemination and IVF technologies: a retrospective cohort study","volume":"27","author":"Sagot","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cjca.2024.09.011_bib84","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S1047951116000743","article-title":"Assisted conception and the risk of CHD: a case-control study","volume":"27","author":"Schofield","year":"2017","journal-title":"Cardiol Young"},{"key":"10.1016\/j.cjca.2024.09.011_bib85","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/heartjnl-2017-312015","article-title":"Cyanotic congenital heart disease following fertility treatments in the United States from 2011 to 2014","volume":"104","author":"Shamshirsaz","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2024.09.011_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejogrb.2010.02.028","article-title":"A\u00a0comprehensive assessment of outcomes in pregnancies conceived by in\u00a0vitro fertilization\/intracytoplasmic sperm injection","volume":"150","author":"Wen","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.cjca.2024.09.011_bib87","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamapediatrics.2019.6096","article-title":"Associations of assisted reproductive technology and twin pregnancy with risk of congenital heart defects","volume":"174","author":"Wen","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.cjca.2024.09.011_bib88","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijcard.2018.04.003","article-title":"Non-inheritable risk factors during pregnancy for congenital heart defects in offspring: a matched case-control study","volume":"264","author":"Feng","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib89","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1442-200X.2011.03341.x","article-title":"Gestational and family risk factors for carriers of congenital heart defects in southern Brazil","volume":"53","author":"Zen","year":"2011","journal-title":"Pediatr Int"},{"key":"10.1016\/j.cjca.2024.09.011_bib90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/AOG.0000000000001775","article-title":"Angiotensin-converting enzyme inhibitors and the risk of congenital malformations","volume":"129","author":"Bateman","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cjca.2024.09.011_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.109.129098","article-title":"Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations","volume":"54","author":"Caton","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2024.09.011_bib92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5271\/sjweh.641","article-title":"Risk factors for cardiovascular malformation: a study based on prospectively collected data","volume":"28","author":"Cedergren","year":"2002","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.cjca.2024.09.011_bib93","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib94","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3109\/14767058.2012.755170","article-title":"Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring: a population-based case-control study","volume":"26","author":"Cs\u00e1ky-Szunyogh","year":"2013","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib95","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00246-013-0749-6","article-title":"Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: a population-based case-control study","volume":"35","author":"Cs\u00e1ky-Szunyogh","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib96","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pds.2068","article-title":"Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta blockers during pregnancy","volume":"20","author":"Davis","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cjca.2024.09.011_bib97","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-009-0620-0","article-title":"Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants","volume":"65","author":"Lennest\u00e5l","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2024.09.011_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5931","article-title":"Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study","volume":"343","author":"Li","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2024.09.011_bib99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/heartasia-2013-010331","article-title":"Maternal hypertension with nifedipine treatment associated with a higher risk for right-sided obstructive defects of the heart: a population-based case-control study","volume":"6","author":"Cs\u00e1ky-Szunyogh","year":"2014","journal-title":"Heart Asia"},{"key":"10.1016\/j.cjca.2024.09.011_bib100","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib101","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2020.2453","article-title":"Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects","volume":"77","author":"Anderson","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cjca.2024.09.011_bib102","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/1471-0528.12682","article-title":"Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study","volume":"121","author":"Ban","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.cjca.2024.09.011_bib103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/bdrb.20099","article-title":"First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage","volume":"80","author":"B\u00e9rard","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.cjca.2024.09.011_bib104","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/pds.1463","article-title":"Paroxetine in the first trimester and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cjca.2024.09.011_bib106","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.20773","article-title":"Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy","volume":"91","author":"Colvin","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cjca.2024.09.011_bib107","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.1462","article-title":"Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy","volume":"16","author":"Davis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cjca.2024.09.011_bib108","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2008.03261.x","article-title":"Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study","volume":"66","author":"Diav-Citrin","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2024.09.011_bib109","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002280050664","article-title":"Delivery outcome after the use of antidepressants in early pregnancy","volume":"55","author":"Ericson","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"issue":"5 Pt 1","key":"10.1016\/j.cjca.2024.09.011_bib110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0029-7844(97)00070-7","article-title":"Effects of first-trimester fluoxetine exposure on the newborn","volume":"89","author":"Goldstein","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib111","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib112","article-title":"Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study","volume":"368","author":"Huybrechts","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2024.09.011_bib113","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001148","article-title":"Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study","volume":"2","author":"Jimenez-Solem","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjca.2024.09.011_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165122","article-title":"Selective serotonin reuptake inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark","volume":"11","author":"Jordan","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.cjca.2024.09.011_bib115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdra.20327","article-title":"Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations","volume":"79","author":"K\u00e4ll\u00e9n","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cjca.2024.09.011_bib116","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2393-14-333","article-title":"Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy: an epidemiological study using validated EUROCAT data","volume":"14","author":"Knudsen","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.cjca.2024.09.011_bib117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CLEP.S9256","article-title":"Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis","volume":"2","author":"Kornum","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib118","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.279.8.609","article-title":"Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study","volume":"279","author":"Kulin","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2024.09.011_bib119","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/jcp.0b013e31815ac4d2","article-title":"Delivery outcome in relation to maternal use of some recently introduced antidepressants","volume":"27","author":"Lennest\u00e5l","year":"2007","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.cjca.2024.09.011_bib120","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pds.3661","article-title":"First-trimester exposure to bupropion and risk of cardiac malformations","volume":"23","author":"Louik","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cjca.2024.09.011_bib121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/AOG.0b013e318220edcc","article-title":"Selective serotonin reuptake inhibitors and risk for major congenital anomalies","volume":"118","author":"Malm","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib122","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/pds.3462","article-title":"Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cjca.2024.09.011_bib123","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdrb.20144","article-title":"Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data","volume":"83","author":"Oberlander","year":"2008","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.cjca.2024.09.011_bib124","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.4088\/JCP.14m09241","article-title":"Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children","volume":"77","author":"Petersen","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.cjca.2024.09.011_bib125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/bdra.23096","article-title":"Association between reported venlafaxine use in early pregnancy and birth defects, National Birth Defects Prevention Study, 1997-2007","volume":"97","author":"Polen","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cjca.2024.09.011_bib126","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1192\/bjp.bp.107.042523","article-title":"Duration of antidepressant use during pregnancy and risk of major congenital malformations","volume":"192","author":"Ramos","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.cjca.2024.09.011_bib127","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib128","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/pds.4844","article-title":"Antidepressant use during pregnancy and risk of congenital heart defects: a case-time-control study","volume":"28","author":"Sun","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cjca.2024.09.011_bib129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/phar.1211","article-title":"Antidepressant use during early pregnancy and the risk of congenital anomalies","volume":"33","author":"Vasilakis-Scaramozza","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjca.2024.09.011_bib130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/84.1.23","article-title":"Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy","volume":"84","author":"Wichman","year":"2009","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.cjca.2024.09.011_bib131","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1176\/appi.ajp.2014.12111402","article-title":"Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study","volume":"171","author":"Diav-Citrin","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cjca.2024.09.011_bib132","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0140-6736(92)90346-5","article-title":"Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester","volume":"339","author":"Jacobson","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2024.09.011_bib133","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","article-title":"Lithium use in pregnancy and the risk of cardiac malformations","volume":"376","author":"Patorno","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib134","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9149(90)91398-P","article-title":"A\u00a0case-control study on the association between first trimester exposure to lithium and Ebstein\u2019s anomaly","volume":"65","author":"Zalzstein","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib135","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/uog.20359","article-title":"Single umbilical artery and risk of congenital malformation: population-based study in Norway","volume":"55","author":"Ebbing","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib136","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4038\/sljch.v50i2.9555","article-title":"Associated factors of congenital heart disease among children in a rural health care setting in Sri Lanka","volume":"50","author":"De Silva","year":"2021","journal-title":"Sri Lanka J Child Health"},{"key":"10.1016\/j.cjca.2024.09.011_bib137","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF00145398","article-title":"Congenital cardiac anomalies relative to selected maternal exposures and conditions during early pregnancy","volume":"8","author":"Shaw","year":"1992","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cjca.2024.09.011_bib138","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001648-200109000-00005","article-title":"Vitamin A and cardiac outflow tract defects","volume":"12","author":"Botto","year":"2001","journal-title":"Epidemiology"},{"key":"10.1016\/j.cjca.2024.09.011_bib139","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1007\/s11356-016-8198-4","article-title":"The influence of maternal exposure history to virus and medicine during pregnancy on congenital heart defects of fetus","volume":"24","author":"Liang","year":"2017","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.cjca.2024.09.011_bib140","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1067\/S0002-9378(03)00645-8","article-title":"Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis","volume":"189","author":"Makrydimas","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib141","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/pd.2124","article-title":"Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis","volume":"28","author":"Wald","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cjca.2024.09.011_bib142","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.12488","article-title":"Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis","volume":"42","author":"Sotiriadis","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib143","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/pd.2281","article-title":"The nuchal translucency and the fetal heart: a literature review","volume":"29","author":"Clur","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cjca.2024.09.011_bib144","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.fertnstert.2012.02.053","article-title":"Birth defects in children conceived by in\u00a0vitro fertilization and intracytoplasmic sperm injection: a meta-analysis","volume":"97","author":"Wen","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjca.2024.09.011_bib145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.rbmo.2018.01.009","article-title":"Multiple pregnancies achieved with IVF\/ICSI and risk of specific congenital malformations: a meta-analysis of cohort studies","volume":"36","author":"Zheng","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.cjca.2024.09.011_bib146","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/uog.18932","article-title":"Congenital heart defects in IVF\/ICSI pregnancy: systematic review and meta-analysis","volume":"51","author":"Giorgione","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cjca.2024.09.011_bib147","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1007\/s43032-023-01252-6","article-title":"Assisted reproductive techniques and risk of congenital heart diseases in children: a systematic review and meta-analysis","volume":"30","author":"Gullo","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.cjca.2024.09.011_bib148","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.111.00833","article-title":"The risk of congenital malformations associated with exposure to \u03b2-blockers early in pregnancy: a meta-analysis","volume":"62","author":"Yakoob","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2024.09.011_bib149","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bcp.14561","article-title":"Risk of congenital malformations in offspring of women using \u03b2-blockers during early pregnancy: an updated meta-analysis of observational studies","volume":"87","author":"Wu","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2024.09.011_bib150","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.4088\/JCP.12r07966","article-title":"Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.cjca.2024.09.011_bib151","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40264-020-01027-x","article-title":"A\u00a0systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants","volume":"44","author":"De Vries","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.cjca.2024.09.011_bib152","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12916-018-1193-5","article-title":"Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births","volume":"16","author":"Gao","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.cjca.2024.09.011_bib153","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.reprotox.2006.03.019","article-title":"Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials","volume":"22","author":"Rahimi","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.cjca.2024.09.011_bib154","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and the risk of congenital heart defects: a meta-analysis of prospective cohort studies","volume":"4","author":"Wang","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2024.09.011_bib155","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1701-2163(16)32918-8","article-title":"Does paroxetine cause cardiac malformations?","volume":"30","author":"O\u2019Brien","year":"2008","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.cjca.2024.09.011_bib156","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/pb.bp.111.035915","article-title":"Risk of cardiovascular malformations after exposure to paroxetine in pregnancy: meta-analysis","volume":"37","author":"Painuly","year":"2013","journal-title":"Psychiatrist"},{"key":"10.1016\/j.cjca.2024.09.011_bib157","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cjca.2024.09.011_bib158","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S2215-0366(18)30180-9","volume":"5","author":"Munk-Olsen","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cjca.2024.09.011_bib159","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","article-title":"A\u00a0reevaluation of risk of in utero exposure to lithium","volume":"271","author":"Cohen","year":"1994","journal-title":"JAMA"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24009498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24009498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T06:44:21Z","timestamp":1733985861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X24009498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":159,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0828282X24009498"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2024.09.011","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of Risk Factors for Congenital Heart Disease: Part 2, Maternal Medication, Reproductive Technologies, and Familial and Fetal Factors","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.07.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}